Cargando…
The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma
Lymphoma is the third most common paediatric cancer. Early detection of high-risk patients is necessary to anticipate those who require intensive therapy and follow-up. Current literature shows that residual tumor avidity on PET (Positron Emission Tomography) following chemotherapy corresponds with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706037/ https://www.ncbi.nlm.nih.gov/pubmed/34945274 http://dx.doi.org/10.3390/jcm10245979 |
_version_ | 1784622094899740672 |
---|---|
author | Reed, Janet Denise Masenge, Andries Buchner, Ane Omar, Fareed Reynders, David Vorster, Mariza Van de Wiele, Christophe Sathekge, Mike |
author_facet | Reed, Janet Denise Masenge, Andries Buchner, Ane Omar, Fareed Reynders, David Vorster, Mariza Van de Wiele, Christophe Sathekge, Mike |
author_sort | Reed, Janet Denise |
collection | PubMed |
description | Lymphoma is the third most common paediatric cancer. Early detection of high-risk patients is necessary to anticipate those who require intensive therapy and follow-up. Current literature shows that residual tumor avidity on PET (Positron Emission Tomography) following chemotherapy corresponds with decreased survival. However, the value of metabolic parameters has not been adequately investigated. In this retrospective study, we aimed to evaluate the prognostic value of metabolic and other parameters in paediatric and adolescent Hodgkin lymphoma. We recorded tMTV (total Metabolic Tumor Volume), TLG (Total Lesion Glycolysis), and SUVmax (maximum Standard Uptake Value) on baseline PET, as well the presence of bone marrow or visceral involvement. HIV (human immunodeficiency virus) status and baseline biochemistry from clinical records were noted. All patients received stage-specific standard of care therapy. Response assessment on end-of-treatment PET was evaluated according to the Deauville criteria. We found that bone marrow involvement (p = 0.028), effusion (p < 0.001), and treatment response (p < 0.001) on baseline PET, as well as HIV status (p = 0.036) and baseline haemoglobin (p = 0.039), were significantly related to progression-free survival (PFS), whereas only effusion (p = 0.017) and treatment response (p = 0.050) were predictive of overall survival (OS). Only baseline tMTV predicted treatment response (p = 0.017). This confirms the value of F-18 FDG PET/CT (Fluoro-deoxy-glucose Positron Emission Tomography/Computed Tomography) in prognostication in paediatric and adolescent Hodgkin lymphoma; however, further studies are required to define the significance of metabolic parameters. |
format | Online Article Text |
id | pubmed-8706037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87060372021-12-25 The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma Reed, Janet Denise Masenge, Andries Buchner, Ane Omar, Fareed Reynders, David Vorster, Mariza Van de Wiele, Christophe Sathekge, Mike J Clin Med Article Lymphoma is the third most common paediatric cancer. Early detection of high-risk patients is necessary to anticipate those who require intensive therapy and follow-up. Current literature shows that residual tumor avidity on PET (Positron Emission Tomography) following chemotherapy corresponds with decreased survival. However, the value of metabolic parameters has not been adequately investigated. In this retrospective study, we aimed to evaluate the prognostic value of metabolic and other parameters in paediatric and adolescent Hodgkin lymphoma. We recorded tMTV (total Metabolic Tumor Volume), TLG (Total Lesion Glycolysis), and SUVmax (maximum Standard Uptake Value) on baseline PET, as well the presence of bone marrow or visceral involvement. HIV (human immunodeficiency virus) status and baseline biochemistry from clinical records were noted. All patients received stage-specific standard of care therapy. Response assessment on end-of-treatment PET was evaluated according to the Deauville criteria. We found that bone marrow involvement (p = 0.028), effusion (p < 0.001), and treatment response (p < 0.001) on baseline PET, as well as HIV status (p = 0.036) and baseline haemoglobin (p = 0.039), were significantly related to progression-free survival (PFS), whereas only effusion (p = 0.017) and treatment response (p = 0.050) were predictive of overall survival (OS). Only baseline tMTV predicted treatment response (p = 0.017). This confirms the value of F-18 FDG PET/CT (Fluoro-deoxy-glucose Positron Emission Tomography/Computed Tomography) in prognostication in paediatric and adolescent Hodgkin lymphoma; however, further studies are required to define the significance of metabolic parameters. MDPI 2021-12-20 /pmc/articles/PMC8706037/ /pubmed/34945274 http://dx.doi.org/10.3390/jcm10245979 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Reed, Janet Denise Masenge, Andries Buchner, Ane Omar, Fareed Reynders, David Vorster, Mariza Van de Wiele, Christophe Sathekge, Mike The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title | The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title_full | The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title_fullStr | The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title_full_unstemmed | The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title_short | The Utility of Metabolic Parameters on Baseline F-18 FDG PET/CT in Predicting Treatment Response and Survival in Paediatric and Adolescent Hodgkin Lymphoma |
title_sort | utility of metabolic parameters on baseline f-18 fdg pet/ct in predicting treatment response and survival in paediatric and adolescent hodgkin lymphoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706037/ https://www.ncbi.nlm.nih.gov/pubmed/34945274 http://dx.doi.org/10.3390/jcm10245979 |
work_keys_str_mv | AT reedjanetdenise theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT masengeandries theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT buchnerane theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT omarfareed theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT reyndersdavid theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT vorstermariza theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT vandewielechristophe theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT sathekgemike theutilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT reedjanetdenise utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT masengeandries utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT buchnerane utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT omarfareed utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT reyndersdavid utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT vorstermariza utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT vandewielechristophe utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma AT sathekgemike utilityofmetabolicparametersonbaselinef18fdgpetctinpredictingtreatmentresponseandsurvivalinpaediatricandadolescenthodgkinlymphoma |